34,817 Shares in Bath & Body Works, Inc. (NYSE:BBWI) Purchased by New Age Alpha Advisors LLC

New Age Alpha Advisors LLC purchased a new stake in Bath & Body Works, Inc. (NYSE:BBWI) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 34,817 shares of the company’s stock, valued at approximately $1,350,000.

Other institutional investors also recently modified their holdings of the company. Golden State Wealth Management LLC bought a new position in Bath & Body Works in the fourth quarter worth $26,000. SRS Capital Advisors Inc. lifted its holdings in shares of Bath & Body Works by 99.7% during the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after acquiring an additional 329 shares during the period. True Wealth Design LLC boosted its position in shares of Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after acquiring an additional 1,054 shares in the last quarter. UMB Bank n.a. increased its stake in Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after acquiring an additional 335 shares during the period. Finally, Lindbrook Capital LLC raised its position in Bath & Body Works by 81.9% in the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after purchasing an additional 431 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Trading Down 3.0 %

Shares of NYSE BBWI opened at $30.93 on Monday. Bath & Body Works, Inc. has a 1 year low of $26.21 and a 1 year high of $52.99. The firm’s 50-day moving average is $35.21 and its 200-day moving average is $34.13. The firm has a market capitalization of $6.63 billion, a PE ratio of 7.54, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $2.79 billion for the quarter, compared to analysts’ expectations of $2.78 billion. As a group, equities research analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were issued a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.59%. Bath & Body Works’s dividend payout ratio is presently 21.98%.

Bath & Body Works declared that its board has initiated a stock buyback program on Thursday, February 27th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to purchase up to 6.4% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s management believes its shares are undervalued.

Analyst Ratings Changes

A number of brokerages have recently issued reports on BBWI. Telsey Advisory Group reissued an “outperform” rating and issued a $43.00 target price on shares of Bath & Body Works in a report on Thursday, February 27th. Wells Fargo & Company upgraded shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $42.00 to $48.00 in a research note on Friday, January 10th. Barclays cut their price target on shares of Bath & Body Works from $43.00 to $38.00 and set an “equal weight” rating for the company in a report on Monday, March 3rd. JPMorgan Chase & Co. set a $47.00 price objective on shares of Bath & Body Works in a research note on Thursday, February 27th. Finally, TD Cowen lifted their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $45.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.